[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$flCyBZkXRikva0GQU-xfpj8wJAHETkgnlKIubLScqxVM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":48,"rows":55},"Nordsjaellands Hospital",[4],88,false,25,3,41203,5,72,[14,16,19,21,23,25,27,30],{"name":15,"count":11},"Postoperative Pain",{"name":17,"count":18},"Community-acquired Pneumonia",4,{"name":20,"count":9},"Abdomen, Acute",{"name":22,"count":9},"Cesarean Section",{"name":24,"count":9},"Pain",{"name":26,"count":9},"Colles' Fracture",{"name":28,"count":29},"Myocardial Injury After Non-cardiac Surgery",2,{"name":31,"count":29},"Myocardial Injury",[33,38,43],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT06564857","Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation","2027-04-01","Remifentanil",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT07136714","Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity","2027-09","Semaglutide Injectable Product",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT06909006","Semaglutide Treatment in Type 1 Diabetes","2028-06","Semaglutide 2.4mg",[49,50,51,52,53,54],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[56,83,101,122,153,171,207,241,269,297,315,361,383,401,419,444,462,490,508,534,552,579,606,624],{"intervention":37,"totalTrials":57,"cells":58},1,{"EARLY_PHASE1":59,"PHASE1":62,"PHASE2":64,"PHASE3":66,"PHASE4":68,"NA":81},{"trials":60,"activeCount":61},[],0,{"trials":63,"activeCount":61},[],{"trials":65,"activeCount":61},[],{"trials":67,"activeCount":61},[],{"trials":69,"activeCount":57,"soonestReadout":36},[70],{"nctId":34,"briefTitle":35,"status":71,"phases":72,"primaryCompletion":36,"completion":73,"start":74,"enrollment":75,"conditions":76,"interventions":80},"RECRUITING",[53],"2027-04-08","2025-11-17",2648,[77,78,37,79],"Tracheal Intubation","Video Laryngoscopy","Rocuronium",[37,79],{"trials":82,"activeCount":61},[],{"intervention":79,"totalTrials":57,"cells":84},{"EARLY_PHASE1":85,"PHASE1":87,"PHASE2":89,"PHASE3":91,"PHASE4":93,"NA":99},{"trials":86,"activeCount":61},[],{"trials":88,"activeCount":61},[],{"trials":90,"activeCount":61},[],{"trials":92,"activeCount":61},[],{"trials":94,"activeCount":57,"soonestReadout":36},[95],{"nctId":34,"briefTitle":35,"status":71,"phases":96,"primaryCompletion":36,"completion":73,"start":74,"enrollment":75,"conditions":97,"interventions":98},[53],[77,78,37,79],[37,79],{"trials":100,"activeCount":61},[],{"intervention":42,"totalTrials":57,"cells":102},{"EARLY_PHASE1":103,"PHASE1":105,"PHASE2":107,"PHASE3":109,"PHASE4":111,"NA":120},{"trials":104,"activeCount":61},[],{"trials":106,"activeCount":61},[],{"trials":108,"activeCount":61},[],{"trials":110,"activeCount":61},[],{"trials":112,"activeCount":57,"soonestReadout":41},[113],{"nctId":39,"briefTitle":40,"status":71,"phases":114,"primaryCompletion":41,"completion":41,"start":115,"enrollment":116,"conditions":117,"interventions":119},[53],"2025-09-11",116,[118],"Major Depressive Disorder",[42],{"trials":121,"activeCount":61},[],{"intervention":47,"totalTrials":57,"cells":123},{"EARLY_PHASE1":124,"PHASE1":126,"PHASE2":128,"PHASE3":130,"PHASE4":149,"NA":151},{"trials":125,"activeCount":61},[],{"trials":127,"activeCount":61},[],{"trials":129,"activeCount":61},[],{"trials":131,"activeCount":57,"soonestReadout":46},[132],{"nctId":44,"briefTitle":45,"status":133,"phases":134,"primaryCompletion":46,"completion":46,"start":135,"enrollment":136,"conditions":137,"interventions":147},"NOT_YET_RECRUITING",[52],"2025-10",122,[138,139,140,141,142,143,144,145,146],"Obesity in Diabetes","Obesity\u002FTherapy","Type 1 Diabetes Mellitus (T1DM)","Insulin Sensitivity\u002FResistance","Semaglutide","Lipidomics","Metabolomics","Weight Loss","Glycemic Control for Diabetes Mellitus",[47,148],"Semaglutide placebo",{"trials":150,"activeCount":61},[],{"trials":152,"activeCount":61},[],{"intervention":148,"totalTrials":57,"cells":154},{"EARLY_PHASE1":155,"PHASE1":157,"PHASE2":159,"PHASE3":161,"PHASE4":167,"NA":169},{"trials":156,"activeCount":61},[],{"trials":158,"activeCount":61},[],{"trials":160,"activeCount":61},[],{"trials":162,"activeCount":57,"soonestReadout":46},[163],{"nctId":44,"briefTitle":45,"status":133,"phases":164,"primaryCompletion":46,"completion":46,"start":135,"enrollment":136,"conditions":165,"interventions":166},[52],[138,139,140,141,142,143,144,145,146],[47,148],{"trials":168,"activeCount":61},[],{"trials":170,"activeCount":61},[],{"intervention":172,"totalTrials":29,"cells":173},"Ropivacaine",{"EARLY_PHASE1":174,"PHASE1":176,"PHASE2":178,"PHASE3":180,"PHASE4":182,"NA":205},{"trials":175,"activeCount":61},[],{"trials":177,"activeCount":61},[],{"trials":179,"activeCount":61},[],{"trials":181,"activeCount":61},[],{"trials":183,"activeCount":61},[184,196],{"nctId":185,"briefTitle":186,"status":187,"phases":188,"primaryCompletion":189,"completion":190,"start":191,"enrollment":192,"conditions":193,"interventions":195},"NCT03326609","Local Anesthetic Concentration and Nerve Block Duration","COMPLETED",[53],"2017-12-08","2018-01-05","2017-10-04",60,[194],"Peripheral Nerve Block",[172],{"nctId":197,"briefTitle":198,"status":187,"phases":199,"primaryCompletion":200,"completion":200,"start":201,"enrollment":202,"conditions":203,"interventions":204},"NCT02829697","The Effect of Local Anaesthetic Volume on Nerve Block Duration and Nerve Block Duration Variability",[53],"2017-03-20","2016-07",120,[15],[172],{"trials":206,"activeCount":61},[],{"intervention":208,"totalTrials":29,"cells":209},"Ropivacaine 0.2%",{"EARLY_PHASE1":210,"PHASE1":212,"PHASE2":214,"PHASE3":216,"PHASE4":218,"NA":239},{"trials":211,"activeCount":61},[],{"trials":213,"activeCount":61},[],{"trials":215,"activeCount":61},[],{"trials":217,"activeCount":61},[],{"trials":219,"activeCount":61},[220,230],{"nctId":221,"briefTitle":222,"status":187,"phases":223,"primaryCompletion":224,"completion":225,"start":226,"enrollment":227,"conditions":228,"interventions":229},"NCT03372265","Catheter-based Peripheral Regional Anesthesia After Total Knee Arthroplasty",[53],"2019-02-01","2019-04-01","2017-12-06",111,[15],[208],{"nctId":231,"briefTitle":232,"status":187,"phases":233,"primaryCompletion":224,"completion":234,"start":235,"enrollment":236,"conditions":237,"interventions":238},"NCT03372304","Catheter-based Peripheral Regional Anesthesia After Orthopedic Surgery to the Foot or Ankle",[53],"2019-02-25","2017-11-29",85,[15],[208],{"trials":240,"activeCount":61},[],{"intervention":242,"totalTrials":57,"cells":243},"Furosemide",{"EARLY_PHASE1":244,"PHASE1":246,"PHASE2":248,"PHASE3":250,"PHASE4":252,"NA":267},{"trials":245,"activeCount":61},[],{"trials":247,"activeCount":61},[],{"trials":249,"activeCount":61},[],{"trials":251,"activeCount":61},[],{"trials":253,"activeCount":61},[254],{"nctId":255,"briefTitle":256,"status":257,"phases":258,"primaryCompletion":259,"completion":259,"start":260,"enrollment":261,"conditions":262,"interventions":266},"NCT02458157","Forced Fluid Removal in High Risk Acute Kidney Injury","TERMINATED",[53],"2017-06-08","2015-10",21,[263,264,265],"Acute Kidney Injury","Fluid Overload","Critical Illness",[242],{"trials":268,"activeCount":61},[],{"intervention":270,"totalTrials":57,"cells":271},"Insulin aspart\u002Fglargine",{"EARLY_PHASE1":272,"PHASE1":274,"PHASE2":276,"PHASE3":278,"PHASE4":280,"NA":295},{"trials":273,"activeCount":61},[],{"trials":275,"activeCount":61},[],{"trials":277,"activeCount":61},[],{"trials":279,"activeCount":61},[],{"trials":281,"activeCount":61},[282],{"nctId":283,"briefTitle":284,"status":187,"phases":285,"primaryCompletion":286,"completion":286,"start":287,"enrollment":288,"conditions":289,"interventions":293},"NCT02192450","Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia",[53],"2019-02-28","2015-01",149,[290,291,292],"Type 1 Diabetes Mellitus","Nocturnal Hypoglycemia","Recurrent Severe Hypoglycaemia",[270,294],"Insulin aspart\u002Fdegludec",{"trials":296,"activeCount":61},[],{"intervention":294,"totalTrials":57,"cells":298},{"EARLY_PHASE1":299,"PHASE1":301,"PHASE2":303,"PHASE3":305,"PHASE4":307,"NA":313},{"trials":300,"activeCount":61},[],{"trials":302,"activeCount":61},[],{"trials":304,"activeCount":61},[],{"trials":306,"activeCount":61},[],{"trials":308,"activeCount":61},[309],{"nctId":283,"briefTitle":284,"status":187,"phases":310,"primaryCompletion":286,"completion":286,"start":287,"enrollment":288,"conditions":311,"interventions":312},[53],[290,291,292],[270,294],{"trials":314,"activeCount":61},[],{"intervention":316,"totalTrials":29,"cells":317},"Lidocaine epinephrine",{"EARLY_PHASE1":318,"PHASE1":320,"PHASE2":322,"PHASE3":324,"PHASE4":357,"NA":359},{"trials":319,"activeCount":61},[],{"trials":321,"activeCount":61},[],{"trials":323,"activeCount":61},[],{"trials":325,"activeCount":61},[326,341],{"nctId":327,"briefTitle":328,"status":187,"phases":329,"primaryCompletion":330,"completion":330,"start":331,"enrollment":332,"conditions":333,"interventions":338},"NCT06379490","Ultrasound-guided Infraclavicular Block With Lidocaine or Ropivacaine for Closed Reduction of Distal Radius Fractures",[52],"2025-06-18","2024-04-23",67,[334,335,172,336,337,26],"Distal Radius Fractures","Lidocaine","Fracture Dislocation","Closed Reduction of Fracture and Application of Plaster Cast",[339,316,340],"Ropivacaine 0.2% Injectable Solution","Ropivacaine 0.5% Injectable Solution",{"nctId":342,"briefTitle":343,"status":187,"phases":344,"primaryCompletion":345,"completion":346,"start":347,"enrollment":348,"conditions":349,"interventions":355},"NCT06381622","Combining Lidocaine and Ropivacaine for an Infraclavicular Brachial Plexus Nerve Block",[52],"2024-10-24","2024-11-23","2024-04-18",78,[350,351,352,353,354],"Nerve Block","Anesthesia, Local","Forearm Fracture","Surgery","Brachial Plexus Block",[340,316,356],"Ropivacaine 0.75% Injectable Solution",{"trials":358,"activeCount":61},[],{"trials":360,"activeCount":61},[],{"intervention":340,"totalTrials":29,"cells":362},{"EARLY_PHASE1":363,"PHASE1":365,"PHASE2":367,"PHASE3":369,"PHASE4":379,"NA":381},{"trials":364,"activeCount":61},[],{"trials":366,"activeCount":61},[],{"trials":368,"activeCount":61},[],{"trials":370,"activeCount":61},[371,375],{"nctId":327,"briefTitle":328,"status":187,"phases":372,"primaryCompletion":330,"completion":330,"start":331,"enrollment":332,"conditions":373,"interventions":374},[52],[334,335,172,336,337,26],[339,316,340],{"nctId":342,"briefTitle":343,"status":187,"phases":376,"primaryCompletion":345,"completion":346,"start":347,"enrollment":348,"conditions":377,"interventions":378},[52],[350,351,352,353,354],[340,316,356],{"trials":380,"activeCount":61},[],{"trials":382,"activeCount":61},[],{"intervention":339,"totalTrials":57,"cells":384},{"EARLY_PHASE1":385,"PHASE1":387,"PHASE2":389,"PHASE3":391,"PHASE4":397,"NA":399},{"trials":386,"activeCount":61},[],{"trials":388,"activeCount":61},[],{"trials":390,"activeCount":61},[],{"trials":392,"activeCount":61},[393],{"nctId":327,"briefTitle":328,"status":187,"phases":394,"primaryCompletion":330,"completion":330,"start":331,"enrollment":332,"conditions":395,"interventions":396},[52],[334,335,172,336,337,26],[339,316,340],{"trials":398,"activeCount":61},[],{"trials":400,"activeCount":61},[],{"intervention":356,"totalTrials":57,"cells":402},{"EARLY_PHASE1":403,"PHASE1":405,"PHASE2":407,"PHASE3":409,"PHASE4":415,"NA":417},{"trials":404,"activeCount":61},[],{"trials":406,"activeCount":61},[],{"trials":408,"activeCount":61},[],{"trials":410,"activeCount":61},[411],{"nctId":342,"briefTitle":343,"status":187,"phases":412,"primaryCompletion":345,"completion":346,"start":347,"enrollment":348,"conditions":413,"interventions":414},[52],[350,351,352,353,354],[340,316,356],{"trials":416,"activeCount":61},[],{"trials":418,"activeCount":61},[],{"intervention":420,"totalTrials":57,"cells":421},"dexamethasone phosphate",{"EARLY_PHASE1":422,"PHASE1":424,"PHASE2":426,"PHASE3":438,"PHASE4":440,"NA":442},{"trials":423,"activeCount":61},[],{"trials":425,"activeCount":61},[],{"trials":427,"activeCount":61},[428],{"nctId":429,"briefTitle":430,"status":187,"phases":431,"primaryCompletion":260,"completion":260,"start":432,"enrollment":433,"conditions":434,"interventions":436},"NCT02415335","Dexamethasone Preoperative for Patients Undergoing Laparoscopy for Suspected Appendicitis",[51],"2015-04",119,[435],"Suspected Appendicitis",[420,437],"Isotonic NaCl",{"trials":439,"activeCount":61},[],{"trials":441,"activeCount":61},[],{"trials":443,"activeCount":61},[],{"intervention":437,"totalTrials":57,"cells":445},{"EARLY_PHASE1":446,"PHASE1":448,"PHASE2":450,"PHASE3":456,"PHASE4":458,"NA":460},{"trials":447,"activeCount":61},[],{"trials":449,"activeCount":61},[],{"trials":451,"activeCount":61},[452],{"nctId":429,"briefTitle":430,"status":187,"phases":453,"primaryCompletion":260,"completion":260,"start":432,"enrollment":433,"conditions":454,"interventions":455},[51],[435],[420,437],{"trials":457,"activeCount":61},[],{"trials":459,"activeCount":61},[],{"trials":461,"activeCount":61},[],{"intervention":463,"totalTrials":57,"cells":464},"Mirtazapine",{"EARLY_PHASE1":465,"PHASE1":467,"PHASE2":469,"PHASE3":484,"PHASE4":486,"NA":488},{"trials":466,"activeCount":61},[],{"trials":468,"activeCount":61},[],{"trials":470,"activeCount":61},[471],{"nctId":472,"briefTitle":473,"status":257,"phases":474,"primaryCompletion":475,"completion":475,"start":476,"enrollment":477,"conditions":478,"interventions":482},"NCT03785691","Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum",[51],"2022-07-31","2019-03-01",58,[479,480,481],"Hyperemesis Gravidarum","Nausea Gravidarum","Vomiting of Pregnancy",[463,483],"Ondansetron",{"trials":485,"activeCount":61},[],{"trials":487,"activeCount":61},[],{"trials":489,"activeCount":61},[],{"intervention":483,"totalTrials":57,"cells":491},{"EARLY_PHASE1":492,"PHASE1":494,"PHASE2":496,"PHASE3":502,"PHASE4":504,"NA":506},{"trials":493,"activeCount":61},[],{"trials":495,"activeCount":61},[],{"trials":497,"activeCount":61},[498],{"nctId":472,"briefTitle":473,"status":257,"phases":499,"primaryCompletion":475,"completion":475,"start":476,"enrollment":477,"conditions":500,"interventions":501},[51],[479,480,481],[463,483],{"trials":503,"activeCount":61},[],{"trials":505,"activeCount":61},[],{"trials":507,"activeCount":61},[],{"intervention":509,"totalTrials":57,"cells":510},"Infusion, Lidocaine, 0.5%, 5 mL",{"EARLY_PHASE1":511,"PHASE1":513,"PHASE2":526,"PHASE3":528,"PHASE4":530,"NA":532},{"trials":512,"activeCount":61},[],{"trials":514,"activeCount":61},[515],{"nctId":516,"briefTitle":517,"status":187,"phases":518,"primaryCompletion":519,"completion":519,"start":520,"enrollment":521,"conditions":522,"interventions":524},"NCT03310047","Intra-individual Reproducibility in Nerve Block Duration",[50],"2018-03-01","2017-10-30",20,[523],"Anesthesia, Regional",[509,525],"Infusion, Lidocaine, 0.5%, 10 mL",{"trials":527,"activeCount":61},[],{"trials":529,"activeCount":61},[],{"trials":531,"activeCount":61},[],{"trials":533,"activeCount":61},[],{"intervention":525,"totalTrials":57,"cells":535},{"EARLY_PHASE1":536,"PHASE1":538,"PHASE2":544,"PHASE3":546,"PHASE4":548,"NA":550},{"trials":537,"activeCount":61},[],{"trials":539,"activeCount":61},[540],{"nctId":516,"briefTitle":517,"status":187,"phases":541,"primaryCompletion":519,"completion":519,"start":520,"enrollment":521,"conditions":542,"interventions":543},[50],[523],[509,525],{"trials":545,"activeCount":61},[],{"trials":547,"activeCount":61},[],{"trials":549,"activeCount":61},[],{"trials":551,"activeCount":61},[],{"intervention":553,"totalTrials":57,"cells":554},"Varying infusion rates of Ropivacaine 0.2%",{"EARLY_PHASE1":555,"PHASE1":557,"PHASE2":571,"PHASE3":573,"PHASE4":575,"NA":577},{"trials":556,"activeCount":61},[],{"trials":558,"activeCount":61},[559],{"nctId":560,"briefTitle":561,"status":257,"phases":562,"primaryCompletion":563,"completion":564,"start":565,"enrollment":192,"conditions":566,"interventions":570},"NCT02801799","Effects of Local Anaesthetic Infusion Rates on Nerve Block Duration",[50],"2016-11-23","2016-12-09","2016-10-10",[567,568,569],"Other Acute Postoperative Pain","Pain, Postoperative","Anaesthesia",[553],{"trials":572,"activeCount":61},[],{"trials":574,"activeCount":61},[],{"trials":576,"activeCount":61},[],{"trials":578,"activeCount":61},[],{"intervention":580,"totalTrials":57,"cells":581},"insulin human",{"EARLY_PHASE1":582,"PHASE1":584,"PHASE2":586,"PHASE3":588,"PHASE4":590,"NA":592},{"trials":583,"activeCount":61},[],{"trials":585,"activeCount":61},[],{"trials":587,"activeCount":61},[],{"trials":589,"activeCount":61},[],{"trials":591,"activeCount":61},[],{"trials":593,"activeCount":61},[594],{"nctId":595,"briefTitle":596,"status":597,"phases":598,"primaryCompletion":599,"completion":599,"start":600,"enrollment":192,"conditions":601,"interventions":603},"NCT05095259","Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes","UNKNOWN",[54],"2023-12","2019-12-16",[602],"Type1diabetes",[580,604,605],"Epinephrin","Glucagon",{"intervention":604,"totalTrials":57,"cells":607},{"EARLY_PHASE1":608,"PHASE1":610,"PHASE2":612,"PHASE3":614,"PHASE4":616,"NA":618},{"trials":609,"activeCount":61},[],{"trials":611,"activeCount":61},[],{"trials":613,"activeCount":61},[],{"trials":615,"activeCount":61},[],{"trials":617,"activeCount":61},[],{"trials":619,"activeCount":61},[620],{"nctId":595,"briefTitle":596,"status":597,"phases":621,"primaryCompletion":599,"completion":599,"start":600,"enrollment":192,"conditions":622,"interventions":623},[54],[602],[580,604,605],{"intervention":605,"totalTrials":57,"cells":625},{"EARLY_PHASE1":626,"PHASE1":628,"PHASE2":630,"PHASE3":632,"PHASE4":634,"NA":636},{"trials":627,"activeCount":61},[],{"trials":629,"activeCount":61},[],{"trials":631,"activeCount":61},[],{"trials":633,"activeCount":61},[],{"trials":635,"activeCount":61},[],{"trials":637,"activeCount":61},[638],{"nctId":595,"briefTitle":596,"status":597,"phases":639,"primaryCompletion":599,"completion":599,"start":600,"enrollment":192,"conditions":640,"interventions":641},[54],[602],[580,604,605]]